Final rule 2026-12905
Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep System
The Food and Drug Administration (FDA) is classifying the infant supine sleep system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the infant supine sleep system. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Source-supplied record
Document details
- Document number
- 2026-12905
- Published
- Jun 26, 2026
- Effective
- Jun 26, 2026
- Comments close
- Not supplied
- Federal Register citation
- 91 FR 38506
Docket identifiers
- Docket No. FDA-2026-N-6710
CFR references
- Title 21, part 880